Company / Current Assets
Omnicell Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$680.1M
FY2025
5-year range
$680.1M / $927.6M
FY2021-FY2025
Trend
-16.6%
vs FY2024
Sector context
#92 of 160
Health Care
What the data says
At $680M, Omnicell's current assets ranks #92 of 160 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $315M in FY2016 to $928M in FY2023.
Based on SEC 10-K filings.
$680M in FY2025 with a 5-year CAGR of -3.9%.
Declined from $928M to $680M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -8.3%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
#92 of 160 in Health CareTop 57% of 160This company $680.1M Sector average $5.2B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.9%, indicating a declining trend.
- In FY2025, current assets decreased 16.6% year-over-year.
- Ranks #92 out of 160 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $680.1M | -16.6% |
| FY2024 | $815.5M | -12.1% |
| FY2023 | $927.6M | +5.2% |
| FY2022 | $881.8M | +13.0% |
| FY2021 | $780.7M | -5.9% |
| FY2020 | $829.4M | +71.6% |
| FY2019 | $483.2M | +21.7% |
| FY2018 | $397.1M | +12.7% |
| FY2017 | $352.3M | +11.7% |
| FY2016 | $315.4M | +19.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026